Ann: Trading Halt, page-65

I doubt AVR investors will ever see any sort of dividend Will . I think the company will be acquired a long time before the TAVR gets approval . The big players will be all over this once AVR is in FDA trials and emulating it’s trial results in Georgia . Let’s hope AVR can raise a heap of capital as they need to be seen to be in a financial position to drive this to approval . This in turn puts prospective buyers in a position where AVR is seen to be under no pressure to sell . If AVR was to drive the TAVR to approval we will be looking at a company worth 10s of billions of dollars something our competitors don’t want . GLTATH